Quanta Research Cambridge

Foundation Medicine, based in Cambridge, MA, is a leading cancer diagnostics company dedicated to providing comprehensive genomic profiling of tumors, thereby transforming cancer care through actionable insights and targeted therapies. Their portfolio includes various tests such as FoundationOne CDx and FoundationOne Liquid CDx, which help identify genomic alterations in cancer to better guide treatment strategies for patients. Committed to advancing precision medicine, Foundation Medicine supports biopharma partners from drug discovery through to clinical development by leveraging one of the world's largest cancer genomic databases, FoundationCore. Their expertise and innovative solutions contribute to the development of new therapies, enabling healthcare professionals to tailor treatments that address the unique characteristics of each cancer patient. Generated from the website